David Goldsteen

Dr. Goldsteen is the co-founder of VigiLanz, and serves as Chairman and CEO. He is a founder and former Chairman and CEO of Vascular Science, Inc., purchased by St. Jude Medical (NASDAQ:STJ). He is the founder and Managing Partner of Global Capital Investments, LLC, a boutique merchant banking group. He previously served as a board member/financier of SurVivaLink, a medical device manufacturer sold to Cardiac Science (NASDAQ:DFIB), MediaDVX, a digital media provider sold to NetStar LP, InfoPet, a veterinary microchipping company, and Quantech, Ltd, a medical diagnostics company. From 1988–1993 he served as Vice President of Medical Affairs for Emergency Services at Health One, a predecessor of Allina Hospitals and Clinics, a diversified healthcare delivery organization. Dr. Goldsteen is a graduate of the University of Minnesota Medical School, performing his residency in Internal Medicine at Hennepin County Medical Center in Minneapolis, MN. He received board certifications in internal medicine and emergency medicine. He received his M.B.A. in 1994 from the Carlson School of Management at the University of Minnesota.